Rheum for Everyone, Episode 24 (video)| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: liver

2024 Traditional MIPS & MVP Final Scores Now Available

Allison Plitman, MPA  |  September 19, 2025

MIPS-eligible clinicians should review their scores to confirm performance. Any scoring concerns can be addressed through a targeted review

Filed under:Quality Assurance/Improvement Tagged with:MIPSQuality Payment Program (QPP)

A New Treatment for Fibromyalgia?

Michele B. Kaufman, PharmD, BCGP  |  September 11, 2025

The FDA has approved a new drug application for TNX-102 SL (Tonmya), a tablet with 2.8 mg of cyclobenzaprine HCl, after two clinical trials demonstrated the safety and effectiveness of the treatment in adults with fibromyalgia.

Filed under:ConditionsDrug UpdatesPain Syndromes Tagged with:Chronic paincyclobenzaprine HCl tabletFDA approvalFibromyalgiaTonmyaU.S. Food and Drug Administration (FDA)

How ACR Volunteers Educate School Nurses About Childhood-Onset Lupus

From the College  |  September 6, 2025

The ACR’s SHOP initiative partners pediatric rheumatologists & school nurses to raise cSLE awareness & better support students living with lupus.

Filed under:From the College Tagged with:childhood-onset SLEChildrenCollaborative Initiatives Committee (COIN)Pediatric RheumatologySchool NursesSLE Resource CenterThe Lupus Initiative

President’s Corner: ACR/ARP Education That Fits

Carol A. Langford, MD, MHS  |  September 6, 2025

Fulfill your lifelong learning goals with the ACR & ARP. Explore diverse educational options, including journals, podcasts & ACR Convergence 2025.

Filed under:President's Perspective Tagged with:ACR Convergence 2025ACR State-of-the-Art Clinical SymposiumACR Winter Rheumatology SymposiumAssociation of Rheumatology Professionals (ARP)continuing medical educationEducationPediatric Rheumatology SymposiumPresident's Corner

AMA State Advocacy Roundtable Addresses Pressing Policy Challenges

From the College  |  September 5, 2025

The roundtable included discussions on emerging issues in state advocacy, prior authorization reform, likely impacts of the Big Beautiful Bill and physician wellness.

Filed under:Legislation & Advocacy Tagged with:AMAstate legislation

ACR President Warns: Access to Care Is at Risk Without Medicare Payment Reform

From the College  |  September 4, 2025

In a recent commentary published by Medscape, ACR President Carol Langford, MD, MHS, issues a stark warning: If Congress does not reform the physician payment system, patients may face increasing difficulty accessing essential medical services.

Filed under:Legislation & AdvocacyPractice Support Tagged with:Medicare Physician Fee Schedule (MPFS)physician payment reform

Editor's Pick

Celebrating Interdisciplinary Collaboration: Pathways to Success

Teresa J. Brady, PhD, MACR, Basia Belza, PhD, RN, FAAN, FGSA, Kimberly Kimpton, PT, MACR, & Marian T. Hannan, DSc, MPH, MACR  |  September 2, 2025

Four past ARP presidents mark the organization’s 60th anniversary by examining its evolution alongside significant challenges & opportunities in the field.

Filed under:From the CollegePractice SupportWorkforce Tagged with:advanced practice providersAssociation of Rheumatology Professionals (ARP)Collaboration Initiativeshealth professionalsHistoryinterdisciplinaryWorkforce

A Sound Diagnosis for Glandular Swelling

Hung Vo, MD, Zhichun Lu, MD, & Eugene Kissin, MD  |  August 26, 2025

In this case study, ultrasonography proves useful for excluding a diagnosis of Sjögren’s disease, leading to a correct diagnosis of IgG4-RD.

Filed under:ConditionsOther Rheumatic ConditionsSjögren’s Disease Tagged with:biopsycase reportglandular swellingIgG4-RDimage case reportimagingmimicssalivary glandsSialadenitisSjögren’s Disease supplementUltrasound

White Bagging: A ‘Prescription for Disruption’ in Rheumatologic Care

From the College  |  August 22, 2025

In a recent op-ed published by MedCity News, rheumatologist and ACR Insurance Subcommittee Chair Michael Feely, MD, delivers a powerful critique of the insurance practice known as white bagging, calling it a “prescription for disruption” that threatens the quality and timeliness of patient care.

Filed under:Insurance Tagged with:ACR Insurance Subcommittee (ISC)white bagging

Lowest Price, Highest Risk? New Drug Policy’s Potential Effect on Rheumatology

From the College  |  August 11, 2025

On July 31, President Trump sent formal letters to the CEOs of 17 major pharmaceutical companies, laying out several requirements the companies must meet within 60 days or face unspecified consequences. These include Most-Favored-Nation pricing for Medicare, Medicaid and private markets.

Filed under:Legal Updates Tagged with:drug pricingMost Favored Nation

  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 127
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences